Clinical trial
Clinical and Economic Outcomes of Ceftaroline Fosamil for the Treatment of Acute Bacterial Skin and Skin Structure Infections Documented or at Risk of Methicillin-Resistant S. Aureus
NCT02582203 is registered in ClinicalTrials.gov with Wayne State University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical and Economic Outcomes of Ceftaroline Fosamil for the Treatment of Acute Bacterial Skin and Skin Structure Infections Documented or at Risk of Methicillin-Resistant S. Aureus
- Lead sponsor
- Wayne State University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 29, 2012
- Completion date
- May 31, 2016
- Enrollment
- 174 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.